Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01757509
Other study ID # ST1
Secondary ID
Status Completed
Phase N/A
First received December 1, 2012
Last updated August 25, 2013
Start date December 2012
Est. completion date August 2013

Study information

Verified date August 2013
Source University of Limerick
Contact n/a
Is FDA regulated No
Health authority Ireland: University of Limerick
Study type Interventional

Clinical Trial Summary

The aim of this study is to investigate if set dancing is beneficial and feasible for those with Parkinson's disease in Ireland. The hypothesis of this feasibility study are that:

- Participants will be able to partake fully in the intervention without reporting adverse events.

- There will be evidence of gains in functional exercise tolerance, balance, motor performance and quality of life in those with Parkinson's disease who participate in eight weeks of set dancing classes compared to a control group.


Description:

Background: Previous research has found that people with Parkinson's disease who participate in dance classes have improved functional exercise capacity, mobility, balance and quality of life (Duncan and Earhart 2012; Hackney and Earhart 2009). Dance may be an effective intervention for people with Parkinson's disease as it targets key components of rehabilitation programmes for people with Parkinson's disease (Earhart 2009). These components include use of cueing strategies, training of muscle power and balance and focusing of attention on movement strategies.

The benefit of many forms of dance have being investigated in people with Parkinson's disease including Tango, (Hackney et al 2007), Contact Improvisation (Marchant et al 2010) and modern dance (Batson 2010). However, recently Irish set dancing has also being found to be beneficial for those with Parkinson's disease (Volpe et al 2013). Irish Set dancing may be beneficial for people with Parkinson's disease as it involves continuous movement initiation and cessation along with focusing of attention on body posture and foot placement. However, research to date has not been conducted in the Irish population. It is important to investigate if set dancing is beneficial for people with Parkinson's disease in Ireland as results may be influenced by the familiarity which the Irish population has for set dancing.

The objectives of the study are:

- To compare functional exercise tolerance, balance, motor performance and quality of life in those with Parkinson's disease before and after participating in set dancing classes, using the following validated outcome measures: Unified Parkinson's Disease Rating Scale 3, Berg Balance Scale, The Parkinson's Disease Questionnaire and The Six-Minute Walk Test.

- To compare functional exercise tolerance, balance, motor performance and quality of life in those with Parkinson's disease participating in set dancing classes to those receiving usual care.

- To assess the effect of the intervention on care giver burden using the Zarit Care Giver Burden Interview.

Participants, who meet inclusion/exclusion criteria, will be randomly assigned to a group who will receive a set dancing intervention along with their usual care or to a control group who will continue with their usual care only. Participants will be assessed the week before the intervention period begins and the week after the intervention period ends using valid and reliable outcome measures.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date August 2013
Est. primary completion date August 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Have a diagnosis of idiopathic Parkinson's disease (Hackney et al 2007; Marchant et al 2010), stage 1-2.5 on the Hoeln and Yahr scale for staging of Parkinson's disease (Batson 2010)

- Showing a clear benefit from anti-Parkinson medication (Marchant et al 2010)

- Able to walk three meters with or without an assistive device (Hackney and Earhart 2009)

- Not pregnant

- Over 18 year of age

- Have a TV and DVD player in their own home to allow them to participate in the home exercise programme.

Exclusion Criteria:

- A serious cardiovascular and/or pulmonary condition (Lodder et al 2004)

- A neurological deficit other than Parkinson's disease (Batson 2010; Marchant et al 2010)

- Evidence of a musculoskeletal problem contraindicating participation in exercise participation(Duncan and Earhart 2012)

- A cognitive or hearing problem which will effect their ability to follow instructions or hear the music (Batson 2010)

- Participated in regular dance classes in the past six months (Marchant et al 2010)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Intervention group
Participants will attend eight weeks of set dancing classes. Each class will be one and a half hours. Family members or volunteers will partner each participant with Parkinson's disease. The class will be led by a Chartered Physiotherapist who is also a set dancing teacher. Set dancing steps and sets will be thought and progressed in line with the participants' abilities. Frequent rests will be taken during the class. Participants will be given a home exercise programme which will involve mental rehearsal, listening to music, watching dance DVD's and practicing dance material in the seated position to reduce the risk of falling.

Locations

Country Name City State
Ireland University of Limerick Limerick Munster

Sponsors (1)

Lead Sponsor Collaborator
University of Limerick

Country where clinical trial is conducted

Ireland, 

References & Publications (3)

Hackney ME, Earhart GM. Effects of dance on gait and balance in Parkinson's disease: a comparison of partnered and nonpartnered dance movement. Neurorehabil Neural Repair. 2010 May;24(4):384-92. doi: 10.1177/1545968309353329. Epub 2009 Dec 14. — View Citation

Hackney ME, Kantorovich S, Levin R, Earhart GM. Effects of tango on functional mobility in Parkinson's disease: a preliminary study. J Neurol Phys Ther. 2007 Dec;31(4):173-9. doi: 10.1097/NPT.0b013e31815ce78b. — View Citation

Marchant D, Sylvester JL, Earhart GM. Effects of a short duration, high dose contact improvisation dance workshop on Parkinson disease: a pilot study. Complement Ther Med. 2010 Oct;18(5):184-90. doi: 10.1016/j.ctim.2010.07.004. Epub 2010 Aug 21. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Berg Balance Scale (To assess change in balance) The aim of the Berg Balance Scale is to assess functional balance (Marigold and Eng 2006). The measure consists of 14 items. Each item requires the participant to perform a functional balance task such as turning, stepping and reaching (Marigold and Eng 2006). A lower score is indicative of compromised balance performance. This measure is a valid and reliable measure and has being found to correlate with UPDRS scores and Hoeln and Yahr scale for staging of Parkinson's disease (Qutubuddin et al 2005). This outcome will be assessed the week before the intervention begins and the week after the intervention period ends. No
Secondary Unified Parkinson's Disease Rating Scale 3 (UPDRS-3) (To assess changes in motor impairment) UPDRS-3 is a motor subscale of the UPDRS. It is a measure of disease severity (Hackney et al 2007). The motor subscale examines various motor impairments which are associated with Parkinson's disease such as speech, tremor at rest, rigidity and gait (Heiberger et al 2011). Higher scores indicate more severe disease stage. This is a disease specific measure which is valid (Hackney et al 2007) and reliable with an excellent Intra-Class Correlation Co-efficient for test re-test reliability (Siderowf et al 2002), and intra-rater reliability (Metman et al 2004). This outcome will be assessed the week before the intervention begins and the week after the intervention period ends. No
Secondary The Parkinson's Disease Questionnaire (PDQ-39) (To assess change in health related quality of life) PDQ-39 will be used to assess health related quality of life (Marchant et al 2010). This questionnaire assesses the impact of Parkinson's disease in eight different areas including mobility, emotional well-being and communication. It has being found to be the most appropriate outcome measure to assess the impact of Parkinson's disease on health related quality of life as it is a disease specific test that is valid and reliable (Hackney et al 2009). Previous research has also found that this measure can detect changes in health related quality of life in response to physical activity interventions (Jenkinson et al 1997). This outcome will be assessed the week before the intervention begins and the week after the intervention period ends. No
Secondary Six-Minute Walk Test (To assess change of functional exercise tolerance) The six-minute walk test will be used to asses functional exercise tolerance (Falvo and Earhart 2009). This test requires participants to walk along a pre measured pathway for six minutes. This test is valid, reliable (Demers et al 2001; Schenkman et al 1997) and clinically applicable as it is simple to reproduce and reflects endurance needed for activities of daily living (Enright 2003). In previous studies, this test has detected changes in exercise tolerance in those with Parkinson's disease who completed a dance intervention (Hackney and Earhart 2009). This outcome will be assessed the week before the intervention begins and the week after the intervention period ends. No
Secondary Zarit Care Giver Burden Interview (ZCBI)(To assess changes in caregiver burden) ZCBI provides a multidimensional assessment of caregiver burden (Ankri et al 2005). The aim of this measure is to assess changes in caregiver burden over time (Hackney et al 2010). It consists of 22 items. Higher scores indicate greater caregiver burden (Hackney et al 2010). It is a valid and reliable measure for assessing the burden of caregivers involved in caring for those with Parkinson's disease (Martínez-Martín et al 2007). This outcome will be assessed the week before the intervention begins and the week after the intervention period ends. No
See also
  Status Clinical Trial Phase
Completed NCT02915848 - Long-term Stability of LFP Recorded From the STN and the Effects of DBS
Recruiting NCT03648905 - Clinical Laboratory Evaluation of Chronic Autonomic Failure
Terminated NCT02688465 - Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE). Phase 4
Completed NCT05040048 - Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
Active, not recruiting NCT04006210 - Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations Phase 3
Completed NCT02562768 - A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease Phase 1
Completed NCT00105508 - Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia Phase 3
Completed NCT00105521 - Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia Phase 3
Recruiting NCT06002581 - Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease N/A
Completed NCT02236260 - Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation N/A
Completed NCT00529724 - Body Weight Gain, Parkinson, Subthalamic Stimulation Phase 2
Active, not recruiting NCT05699460 - Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
Completed NCT03703570 - A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations Phase 2
Completed NCT03462680 - GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures N/A
Completed NCT02837172 - Diagnosis of PD and PD Progression Using DWI
Not yet recruiting NCT04046276 - Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease N/A
Recruiting NCT02952391 - Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol N/A
Active, not recruiting NCT02937324 - The CloudUPDRS Smartphone Software in Parkinson's Study. N/A
Terminated NCT02924194 - Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease N/A
Completed NCT02927691 - Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial Phase 2